Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor
- PMID: 14662017
- PMCID: PMC11160104
- DOI: 10.1111/j.1349-7006.2003.tb01397.x
Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor
Abstract
Hepatoma-derived growth factor (HDGF) is highly expressed in tumor cells, and stimulates their proliferation. In the present study, we investigated the role of HDGF in tumorigenesis and elucidated the mechanism of action. Stable transfectants of NIH3T3 cells overexpressing HDGF did not show significant anchorage-independent growth in soft agar assay. However, these stable transfectants overexpressing HDGF generated sarcomatous tumors in nude mice. These tumors were red-colored macroscopically, and histologically showed a rich vascularity. Immunohistochemical analysis using CD31 antibody showed new vessel formation. Recombinant HDGF stimulated proliferation of human umbilical vein endothelial cells in a dose-dependent manner, and stimulated tubule formation. Furthermore, vascular endothelial growth factor (VEGF) was detected immunohistochemically in the tumor tissues. Transient expression of HDGF induced both VEGF gene and protein expression as demonstrated by a reporter assay using VEGF gene promoter. The administration of anti-VEGF neutralizing antibody significantly suppressed, but did not block, the tumor growth of HDGF-overexpressing cells in nude mice. Thus, these findings suggested that HDGF-induced tumor formation in vivo involves induction of VEGF as well as direct angiogenic activity.
Similar articles
-
The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.Mol Vis. 2016 Apr 23;22:374-86. eCollection 2016. Mol Vis. 2016. PMID: 27122967 Free PMC article.
-
Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.BMC Cancer. 2019 Nov 11;19(1):1083. doi: 10.1186/s12885-019-6229-5. BMC Cancer. 2019. PMID: 31711427 Free PMC article.
-
MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.J Hepatol. 2012 Sep;57(3):584-91. doi: 10.1016/j.jhep.2012.04.031. Epub 2012 May 18. J Hepatol. 2012. PMID: 22613005
-
Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor.Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1194-201. doi: 10.1152/ajplung.00427.2003. Epub 2004 Jan 29. Am J Physiol Lung Cell Mol Physiol. 2004. PMID: 14751852
-
Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.Int J Mol Sci. 2015 Jun 19;16(6):14086-97. doi: 10.3390/ijms160614086. Int J Mol Sci. 2015. PMID: 26101867 Free PMC article. Review.
Cited by
-
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58. Diagn Pathol. 2010. PMID: 20846397 Free PMC article.
-
Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain.BMC Mol Biol. 2007 Oct 31;8:101. doi: 10.1186/1471-2199-8-101. BMC Mol Biol. 2007. PMID: 17974029 Free PMC article.
-
High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.Dis Markers. 2014;2014:298795. doi: 10.1155/2014/298795. Epub 2014 Feb 17. Dis Markers. 2014. PMID: 24692842 Free PMC article.
-
The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.Mol Vis. 2016 Apr 23;22:374-86. eCollection 2016. Mol Vis. 2016. PMID: 27122967 Free PMC article.
-
Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy.Clin Cancer Res. 2013 Jul 1;19(13):3567-76. doi: 10.1158/1078-0432.CCR-12-3478. Epub 2013 May 21. Clin Cancer Res. 2013. PMID: 23695169 Free PMC article.
References
-
- Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S. Oncogenes and signal transduction. Cell 1991; 64: 281–302. - PubMed
-
- Munger K. Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest 2002; 20: 71–81. - PubMed
-
- Wakefield LM, Roberts AB. TGF‐beta signaling:positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002; 12: 22–29. - PubMed
-
- MacArthur CA, Lawshe A, Shankar DB, Heikinheimo M, Shackleford GM. FGF‐8 isoforms differ in NIH3T3 cell transforming potential. Cell Growth Differ 1995; 6: 817–25. - PubMed
-
- Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I, Resau J. Met‐HGF/SF: tumorigenesis, invasion and metastasis. Ciba Found Symp 1997; 212: 119–30. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources